SCHEMBL887124

SCHEMBL887124

CC(=O)Nc1nc(O)c2nc[nH]c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
GDA Q9Y2T3 1/20 0.39
POLB P06746 1/20 0.39
ADORA3 P0DMS8 5/20 0.37
ADORA1 P30542 1/20 0.37
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 1/20 0.34
HTR1A P08908 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
HTR1F P30939 1/20 0.34
ALDH1A1 P00352 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
RAB9A P51151 1/20 0.33
BRAF P15056 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALPL P05186 1/20 0.33
CTSS P25774 1/20 0.32
NEK2 P51955 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9021288 0.84 CYP1A2 (0.40) CYP1A2GDAPOLBADORA3ADORA1
SCHEMBL4777464 0.83 ADORA1 (0.41) ADORA1LMNAALDH1A1RAB9AKDM4E
SCHEMBL14938903 0.83 CYP1A2 (0.39) CYP1A2GDAPOLBADORA3ADORA1
SCHEMBL17595245 0.83 CYP1A2 (0.39) CYP1A2GDAPOLBADORA3ADORA1
SCHEMBL5197095 0.83 CYP1A2 (0.39) CYP1A2GDAPOLBADORA3ADORA1
SCHEMBL9412566 0.81 KDM4E (0.35) LMNAALDH1A1L3MBTL1RAB9AKDM4E
SCHEMBL9412633 0.80 ALDH1A1 (0.35) ALDH1A1L3MBTL1KDM4E
SCHEMBL9412613 0.80 JAK3 (0.32) ALDH1A1
SCHEMBL377762 0.80 PDPK1 (0.33) POLBLMNA
SCHEMBL802554 0.77 CYP1A2 (0.38) CYP1A2GDAPOLBADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4560315-A2 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES F. Hoffmann-La Roche AG (CH) 2025-05-28 EP claimed
EP-3980554-B1 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES HOFFMANN LA ROCHE (CH) 2025-03-26 EP claimed
US-20240368505-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF Tan Kah Kee Innovation Laboratory (CN) 2024-11-07 US claimed
WO-2023133876-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF 嘉庚创新实验室 2023-07-20 WO claimed
CN-111777611-B Preparation method of acyclovir intermediate N (2), 9-diacetylguanine 潍坊奥通药业有限公司 2022-11-04 CN claimed
US-20220195497-A1 HYBRIDIZING all-LNA OLIGONUCLEOTIDES ROCHE DIAGNOSTICS OPERATIONS, INC. 2022-06-23 US claimed
CN-113292564-B Synthetic method of 2-amino-6-chloropurine 上海凌凯医药科技有限公司 2022-04-19 CN claimed
EP-3980554-A1 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES F. Hoffmann-La Roche AG (CH) 2022-04-13 EP claimed
CN-114317127-A Fluoride-free cleaning agent, and preparation method and application thereof 嘉庚创新实验室 2022-04-12 CN claimed
CN-113939599-A Hybrid all-LNA oligonucleotides 豪夫迈·罗氏有限公司 2022-01-14 CN claimed
CN-113292564-A Synthetic method of 2-amino-6-chloropurine 上海凌凯医药科技有限公司 2021-08-24 CN claimed
WO-2020245377-A1 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES F. HOFFMANN-LA ROCHE AG (CH) 2020-12-10 WO claimed
CN-111777611-A Preparation method of acyclovir intermediate N (2), 9-diacetylguanine 潍坊奥通药业有限公司 2020-10-16 CN claimed
EP-4560315-A2 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES F. Hoffmann-La Roche AG (CH) 2025-05-28 EP disclosed
EP-3980554-B1 HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES HOFFMANN LA ROCHE (CH) 2025-03-26 EP disclosed
US-20240368505-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF Tan Kah Kee Innovation Laboratory (CN) 2024-11-07 US disclosed
US-5256806-A Intermediates for the preparation of optically active cyclobutane nucleoside E. R. SQUIBB & SONS, INC. (US) 1993-10-26 US disclosed
US-5198583-A Optically active cyclobutane nucleoside and intermediates, therefor E. R. SQUIBB & SONS, INC. (US) 1993-03-30 US disclosed
US-5064961-A PROCESS FOR PREPARING AN OPTICALLY ACTIVE CYCLOBUTANE NUCLEOSIDE E. R. SQUIBB & SONS, INC. (US) 1991-11-12 US disclosed
EP-0433897-A2 Process for preparing an optically active cyclobutane nucleoside E.R. SQUIBB & SONS, INC. (US) 1991-06-26 EP disclosed